-
Opella and JD Healthcare Collaborate to Enhance Fatty Liver Awareness in China
•
Opella, the consumer health business of French giant Sanofi (EPA: SAN, NASDAQ: SNY), held a collaboration press conference with JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), in Beijing this week. The collaboration aims to jointly enhance public awareness of fatty liver through activities such as doctor-patient…
-
Bayer HealthCare and JD Healthcare Partner on Women’s Health Ecosystem
•
German pharmaceutical giant Bayer HealthCare (ETR: BAYN) has entered into a new partnership with JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), focusing on women’s health. The collaboration aims to establish a comprehensive health management ecosystem covering the entire life cycle of women, integrating Bayer’s medical expertise…
-
JD Healthcare and Genrix Bio Join Forces to Revolutionize Patient Care and Pharmacy Services
•
JD Healthcare, a subsidiary of China’s e-commerce juggernaut JD.com (NASDAQ: JD), has formed a strategic partnership with Chongqing Genrix Biopharmaceutical Co., Ltd. This alliance combines Genrix Biopharmaceutical’s prowess in drug research and development with JD Healthcare’s extensive resource and ecological advantages in medical treatment, medication, health management, and insurance. Together,…
-
Eisai and Biogen Launch Alzheimer’s Drug Leqembi in China Following Market Approval
•
Eisai Co., Ltd (TYO: 4523), a Japanese pharmaceutical company, in partnership with Biogen Inc. (NASDAQ: BIIB), has announced the official market launch of Leqembi (lecanemab), a therapy for Alzheimer’s disease (AD), in China. This follows the drug’s official market approval in China in January this year. Leqembi is a humanized…
-
JD Healthcare Forges Partnerships with Top Medical Device Firms at CMEF
•
The China International Medical Equipment Fair (CMEF), which took place last week in Shanghai, was a significant event for JD Healthcare, a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD). The company announced a series of strategic partnerships with prominent medical device firms, including Yuyue Medical, Omron, Cofoe Medical, Philips,…
-
JD Healthcare Reports 34% Revenue Growth and Triples Non-IFRS Profits in 2023 Interim Report
•
JD Healthcare, a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD), has released its 2023 interim financial report, showing a 34% year-on-year (YOY) increase in total revenues to RMB 27.11 billion (USD 3.72 billion). Non-IFRS net profits surged by 101.2% to RMB 2.44 billion (USD 334.7 million), indicating strong financial…
-
Omron Healthcare and JD Healthcare Form Partnership to Innovate Chronic Disease Management
•
At the China International Medical Equipment Fair (CMEF), Omron Healthcare, a leading provider of healthcare equipment, has announced a new partnership with JD Healthcare, a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD). This strategic alliance aims to establish a comprehensive chronic disease management system that integrates both online and…
-
JD Healthcare Partners with Jiangsu Yuyue for Medical Device Collaboration
•
JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), has announced a partnership with compatriot firm Jiangsu Yuyue Medical Equipment Inc. (SHE: 002223). The collaboration aims to leverage JD Healthcare’s healthcare supply chain and service advantages, combined with Yuyue Med’s expertise in the medical device field, to enhance…
-
JD Healthcare’s H1 2022 Financial Report Shows Strong Growth in Revenue and Profits
•
JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), reported robust financial results for H1 2022, with total revenues reaching RMB 20.2 billion (USD 2.94 billion), up 48.3% year-on-year (YOY). Non-IFRS net profits surged 82.0% YOY to RMB 1.21 billion (USD 176.6 million). As of June 30, 2022,…
